Physician Marketing 2025

Pharma Doctor Outreach Rises as D2C Drug Ads Face Scrutiny

Download
Share
About This Report
With tighter rules looming for D2C drug ads, pharma must strengthen its marketing efforts to healthcare professionals (HCPs). Delivering data-driven outreach and credible clinical content on digital channels that physicians frequent will be key to sustaining drug awareness and prescriptions amid declining HCP access.
Table of Contents

Tougher D2C ad regulations will push pharma to rely more on doctors for patient drug education and prescription growth. This report examines how pharma marketers can more effectively use digital tools and channels to create credible engagement strategies that offset decreased consumer exposure.

Key Question: How are physician preferences for pharma content consumption evolving, and how can marketers use digital tools to better engage them?

Key Stat: Healthcare and pharma marketers will spend $2.11 billion on B2B digital ad spending in 2025, up 10.7% YoY, reaching $2.54 billion by 2027.

authors

Rajiv Leventhal

Contributors

Beth Snyder Bulik
Eleni Digalaki
Nikolai Dineros
Donte Gibson
Senior Charts Editor
Jennifer Pearson
VP, Research
Heather Sprung
Senior Editor
Emman Velasco
Chart Editor
Paul Verna
VP, Content
Unlock Unlimited Insights with PRO+